Private‑market analysts have seized on the debate over the role of control‑value agreements, or CVs, arguing they entrench managers or delay exits. In a recent piece, John Garcia of AEA Investors and Painswick Capital counters that, when structured with transparency, CVs align interests rather than obscure them. The article frames the discussion as a matter of investor risk.

Garcia points out that the private‑markets sector, often under scrutiny for its leverage and exit timing, can benefit from the clarity CVs provide. By locking in valuations and exit schedules, fund managers and limited partners gain a shared horizon, reducing friction when the market turns. The piece stresses that this alignment can curb volatility.

Critics claim CVs lock in managers, but the article argues the opposite: they create a predictable exit path that protects investors. The argument hinges on the premise that transparency in exit timing reduces opportunistic behaviour and aligns incentives between general partners and limited partners. This clarity, the author says, strengthens capital deployment.

For fund managers, adopting CVs means committing to a schedule that can be audited by investors, potentially easing fundraising and reducing conflict. Limited partners, meanwhile, receive a clearer view of exit timing and valuation, improving risk assessment. The article concludes that, under proper governance, CVs serve investors rather than obstruct them.